Medication info

Seoul Lansoprazole Capsule 30 mg (Lansoprazole Granule)

Prescription medicationHard capsuleOralExpired
Ingredient · strength
Lansoprazole Granules›353mg / 1 capsule
Manufacturer / importer
Seoul Pharmaceutical Co., Ltd.
Appearance
A hard capsule with a white or almost white spherical or oval granule filled inside that has white color on both ends.
Packaging
30 capsules/bottle, 100 capsules/bottle
Approval status
Expired

MFDS item code 201902807 · Approved 2019.04.30

This product's status changed to Expired on 2024.04.30. It may no longer be sold, so consult a doctor or pharmacist before taking it.

Summary

Main use
Treatment and prevention of gastric and duodenal ulcers (including eradication therapy), gastroesophageal reflux disease, and gastric acid hypersecretion
Who takes it
Adults · Children
Adult dose
This drug should be administered before meals. For patients who have difficulty swallowing the medication, open the capsule, mix this drug with a small amount (60 mL) of orange juice or tomato juice, and administer immediately. To ensure the entire dose is taken, rinse the glass with twice or more the amount of juice and drink immediately. After opening this drug, do not chew or crush it before taking it. Short-term treatment of active duodenal ulcers: Administer lansoprazole 15 mg orally once daily for 4 weeks. Short-term treatment of active benign gastric ulcers: Administer lansoprazole 30 mg orally once daily for 8 weeks. Eradication of Helicobacter pylori to prevent recurrence of duodenal ulcers 1) Administer lansoprazole 30 mg with clarithromycin 250 ∼ 500 mg and amoxicillin 1,000 mg twice daily (every 12 hours) for 7 days. Administration may be continued for up to 14 days if necessary. 2) Administer lansoprazole 30 mg with amoxicillin 1,000 mg 3 times daily (every 8 hours) for 14 days. Maintenance therapy after treatment of duodenal ulcers: Administer lansoprazole 15 mg orally once daily. The duration of comparative clinical trials did not exceed 12 months. Treatment of NSAID-induced gastric ulcers: Administer lansoprazole 30 mg orally once daily for 8 weeks. The duration of comparative clinical trials did not exceed 8 weeks. Reduction in the risk of NSAID-induced gastric ulcers: Administer lansoprazole 15 mg orally once daily for 12 weeks. The duration of comparative clinical trials did not exceed 12 weeks. Short-term treatment of symptoms associated with gastroesophageal reflux disease Administer lansoprazole 15 mg orally once daily for 8 weeks Short-term treatment of erosive reflux esophagitis: Administer lansoprazole 30 mg orally once daily for 8 weeks. Maintenance therapy after treatment of erosive reflux esophagitis: Administer lansoprazole 15 mg orally once daily. Pathological hypersecretory conditions, including Zollinger-Ellison syndrome The dose of lansoprazole for pathological hypersecretory conditions varies from patient to patient. Treatment is usually initiated in adults at 60 mg once daily. The dose should be adjusted according to the patient’s needs and may be continued for as long as it is clinically effective. Doses of 90 mg twice daily have been administered. If the daily dose exceeds 120 mg, it should be administered in divided doses. Since clearance of this drug is reduced in elderly patients, dosage adjustment is necessary. Do not exceed a daily dose of 30 mg. Since metabolism and excretion of this drug may be delayed in patients with hepatic impairment, administer cautiously, including dose adjustment.
Child dose
Children and adolescents aged 12 ∼ 17 years — Short-term treatment of symptoms associated with non-erosive gastroesophageal reflux disease: 15 mg once daily for 8 weeks Children and adolescents aged 12 ∼ 17 years — Short-term treatment of erosive reflux esophagitis: 30 mg once daily for 8 weeks Children aged 1 ∼ 11 years — 30 kg or less: 15 mg once daily for 12 weeks Children aged 1 ∼ 11 years — Over 30 kg: 30 mg once daily for 12 weeks

Ingredients

Manufacturer
Seoul Pharmaceutical Co., Ltd.

Efficacy & effects

Treatment and prevention of gastric and duodenal ulcers (including eradication therapy), gastroesophageal reflux disease, and gastric acid hypersecretion

  • Active duodenal ulcer
  • active benign gastric ulcer
  • duodenal ulcer
  • NSAID-induced gastric ulcer
  • symptoms related to gastroesophageal reflux disease
  • erosive esophagitis
  • Zollinger-Ellison syndrome
  • pathological hypersecretion states.
View approved original text

This medication is used for short-term treatment of active duodenal ulcers and active benign gastric ulcers. It is also effective in eradicating Helicobacter pylori to prevent the recurrence of duodenal ulcers. It can be used as a maintenance therapy after treatment and helps in the treatment and risk reduction of NSAID-induced gastric ulcers. It is used for short-term treatment and maintenance of gastroesophageal reflux disease and erosive esophagitis. Lastly, it is effective in treating pathological hypersecretion states such as Zollinger-Ellison syndrome. Overall, it is used to improve symptoms of ulcers in the stomach and duodenum and related diseases.

How to take

Adult dose

This drug should be administered before meals. For patients who have difficulty swallowing the medication, open the capsule, mix this drug with a small amount (60 mL) of orange juice or tomato juice, and administer immediately. To ensure the entire dose is taken, rinse the glass with twice or more the amount of juice and drink immediately. After opening this drug, do not chew or crush it before taking it. Short-term treatment of active duodenal ulcers: Administer lansoprazole 15 mg orally once daily for 4 weeks. Short-term treatment of active benign gastric ulcers: Administer lansoprazole 30 mg orally once daily for 8 weeks. Eradication of Helicobacter pylori to prevent recurrence of duodenal ulcers 1) Administer lansoprazole 30 mg with clarithromycin 250 ∼ 500 mg and amoxicillin 1,000 mg twice daily (every 12 hours) for 7 days. Administration may be continued for up to 14 days if necessary. 2) Administer lansoprazole 30 mg with amoxicillin 1,000 mg 3 times daily (every 8 hours) for 14 days. Maintenance therapy after treatment of duodenal ulcers: Administer lansoprazole 15 mg orally once daily. The duration of comparative clinical trials did not exceed 12 months. Treatment of NSAID-induced gastric ulcers: Administer lansoprazole 30 mg orally once daily for 8 weeks. The duration of comparative clinical trials did not exceed 8 weeks. Reduction in the risk of NSAID-induced gastric ulcers: Administer lansoprazole 15 mg orally once daily for 12 weeks. The duration of comparative clinical trials did not exceed 12 weeks. Short-term treatment of symptoms associated with gastroesophageal reflux disease Administer lansoprazole 15 mg orally once daily for 8 weeks Short-term treatment of erosive reflux esophagitis: Administer lansoprazole 30 mg orally once daily for 8 weeks. Maintenance therapy after treatment of erosive reflux esophagitis: Administer lansoprazole 15 mg orally once daily. Pathological hypersecretory conditions, including Zollinger-Ellison syndrome The dose of lansoprazole for pathological hypersecretory conditions varies from patient to patient. Treatment is usually initiated in adults at 60 mg once daily. The dose should be adjusted according to the patient’s needs and may be continued for as long as it is clinically effective. Doses of 90 mg twice daily have been administered. If the daily dose exceeds 120 mg, it should be administered in divided doses. Since clearance of this drug is reduced in elderly patients, dosage adjustment is necessary. Do not exceed a daily dose of 30 mg. Since metabolism and excretion of this drug may be delayed in patients with hepatic impairment, administer cautiously, including dose adjustment.

Child dose

Children and adolescents aged 12 ∼ 17 years — Short-term treatment of symptoms associated with non-erosive gastroesophageal reflux disease: 15 mg once daily for 8 weeks Children and adolescents aged 12 ∼ 17 years — Short-term treatment of erosive reflux esophagitis: 30 mg once daily for 8 weeks Children aged 1 ∼ 11 years — 30 kg or less: 15 mg once daily for 12 weeks Children aged 1 ∼ 11 years — Over 30 kg: 30 mg once daily for 12 weeks

Precautions

This medication should not be used in patients with specific allergic reactions or those who have shown hypersensitivity to similar components. It should be avoided especially in patients who are allergic to penicillin antibiotics or macrolide antibiotics or are taking certain heart-related medications. Pregnant or breastfeeding women should also avoid using this medication. Patients with impaired liver function, elderly patients, children, and those with a history of drug allergies should use this medication with caution. This medication can rarely cause serious allergic reactions or blood disorders, liver dysfunction, severe skin disorders, etc., so if unusual symptoms occur, medical advice should be sought immediately. Long-term use may lead to nutrient deficiencies such as vitamin B12 deficiency or hypomagnesemia, so regular testing is needed. Additionally, this medication can interact with other drugs, so if taking other medications, be sure to inform your doctor or pharmacist. Especially when used in conjunction with antibiotics, caution should be exercised if gastrointestinal symptoms such as diarrhea occur, and in severe cases, treatment may be required. Dizziness, drowsiness, and visual disturbances may occur while driving or operating machinery, so caution is advised. In case of overdose, as there is no specific antidote, immediate medical attention should be sought. This medication should be kept out of reach of children and should not be transferred to other containers.

Side effects

Anaphylaxis, anaphylactic shock, angioedema, bronchospasm, acute interstitial nephritis, urticaria, generalized rash, facial swelling, dyspnea, shock, pancytopenia, agranulocytosis, hemolytic anemia, neutropenia, thrombocytopenia, anemia, jaundice, elevated AST, elevated ALT, toxic hepatitis, toxic epidermal necrolysis, Stevens-Johnson syndrome, DRESS syndrome, interstitial pneumonia, fever, cough, abnormal lung sounds, interstitial nephritis, acute kidney failure, membranous colitis, hematochezia, abdominal pain, diarrhea, headache, abdominal enlargement, allergic reaction, back pain, weakness, candidiasis, carcinoma, chills, chest pain, edema, fever, flu symptoms, halitosis, infection, fatigue, neck stiffness, pelvic pain, angina, arrhythmia, bradycardia, tachycardia, cerebrovascular accident, cerebral infarction, hypertension, hypotension, migraine, myocardial infarction, palpitations, vasodilation, syncope, asthma, bronchitis, increased cough, epistaxis, hemoptysis, hiccups, pneumonia, upper respiratory infection, laryngeal tumor, pulmonary fibroma, pharyngitis, pleural disorders, respiratory disorders, rhinitis, sinusitis, wheezing, acne, hair loss, pruritus, rash, contact dermatitis, dry skin, nail disorders, skin cancer, skin diseases, sweating, abnormal vision, amblyopia, blepharitis, cataract, conjunctivitis, dry eyes, ear disorders, eye disorders, glaucoma, abnormal olfaction, photophobia, retinal degeneration, loss of taste, blurred vision, deafness, ocular pain, otitis media, taste disorder, tinnitus, visual field constriction, urination disorders, renal pain, penile disorders, testicular disorders, urethral pain, polyuria, urinary frequency, urinary retention, menstrual irregularities, chest tenderness, chest expansion, gynecomastia, diabetes, hematuria, erectile dysfunction, nephrolithiasis, abdominal pain, vomiting, pancreatitis, taste abnormalities, aplastic anemia, thrombocytopenia, thrombotic thrombocytopenic purpura, eosinophilia, hypomagnesemia, Clostridium difficile-associated diarrhea, fractures, myositis, erythema multiforme, systemic lupus erythematosus, discoid lupus erythematosus, speech disorders, urinary retention, elevated AST, elevated ALT, elevated ALP, elevated LDH, elevated γ-GTP, fatigue, hyponatremia, elevated total cholesterol, decreased total cholesterol, tongue paralysis, lip paralysis, limb paralysis, constipation, dizziness, lightheadedness, insomnia, paralysis, depressive state, drowsiness, headache, taste disorder, abdominal distension, stomatitis, glossitis, thirst, heartburn, gastroesophageal reflux, loss of appetite, elevated triglycerides, elevated uric acid, positive urine protein, positive urine glucose, fatigue, convulsions, dementia, depersonalization, diplopia, hyperkinesia, hypertonia, sensory loss, insomnia, sleep disorders, drowsiness, tremors, anxiety, loss of interest, confusion, hallucinations, unilateral paralysis, exacerbation of hostility, decreased libido, increased libido, neurosis, sensory abnormalities, abnormal thoughts, wheezing, discoid lupus erythematosus, systemic lupus erythematosus, Stevens-Johnson syndrome, toxic epidermal necrolysis, eosinophilia, drug reactions with systemic symptoms, acute generalized pustular psoriasis

Not everyone experiences these, and they can vary from person to person.

Storage

This medication may be sensitive to air and moisture, so it should be stored in a tightly closed container. It is important to maintain a storage temperature between 1 degree and 30 degrees Celsius to safely preserve the medication's effectiveness for a long time.

Appearance and packaging

Appearance

A hard capsule with a white or almost white spherical or oval granule filled inside that has white color on both ends.

Package unit

30 capsules/bottle, 100 capsules/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.